Content about Growth hormone treatment

November 10, 2010

The Food and Drug Administration has approved a drug for treating excess fat development in...

SILVER SPRING, Md. The Food and Drug Administration has approved a drug for treating excess fat development in patients with HIV, the agency said Thursday.

 

The FDA approved Egrifta (tesamorelin) for treating HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, such as the abdominal organs. The condition is often a side effect of the retroviral drugs used to treat the disease.

 

 

August 26, 2010

The FDA approved Sandoz Omnitrope (somatropin [rDNA origin]) as a treatment for idiopathic short stature,...

June 27, 2010

The Food and Drug Administrations has approved two new uses for what remains, thus far,...